Therapeutics: Core-binding factor β subunit (CBFB; CBF-β); myosin heavy chain 11 smooth muscle (MYH11; SMMHC); runt-related transcription factor 1 (RUNX1)
Cancer
INDICATION: Acute myelogenous leukemia (AML)
In vitro, mouse and patient sample studies suggest a small molecule protein-protein inhibitor could
